Back to User profile » Dr Osamu Hataji

Papers published by Dr Osamu Hataji:


Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002

Published Date: 23 December 2019

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991

Published Date: 23 December 2019

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

Hataji O, Naito M, Ito K, Watanabe F, Gabazza EC, Taguchi O

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:1-5

Published Date: 28 December 2012